No items found.

View Article PDF

Visual changes are a common presentation to the emergency department and appropriate work-up is paramount. This case shows how fundoscopy findings alone alerted the medical practitioners to a life-changing, exceedingly rare systemic illness. Preretinal haemorrhages form between the hyaloid face and the inner limiting membrane of the retina, and may occur in cases of diabetes, trauma or older age.[[1]] However, in younger patients it is an uncommon clinical finding. This is the first reported case of B-cell prolymphocytic leukaemia (B-PLL) presenting with visual symptoms.

Case report

A 39-year-old Caucasian man presented to the emergency eye clinic with left eye visual field changes. Initially it was described as a haze with shimmering lights, which then progressed to a small central scotoma (blind spot). The patient had no other associated ocular symptoms nor a history of trauma. However, on further questioning, he reported an unintended weight loss of 20 kilograms over the prior 2 months. This was attributed to a loss of appetite since starting a new medication (methylphenidate).

At presentation, his Snellen visual acuities were 6/4.5 in the right, and 6/7.5 in the left eye. The slit-lamp exam revealed a small oval-shaped pre-retinal haemorrhage inferonasal to the fovea in the left eye, as seen in the figure.

The differential diagnosis for a young patient with a preretinal haemorrhage includes trauma, valsalva retinopathy, retinal arteriolar macroaneurysm and blood disorders. As there was no history of valsalva maneuver nor hypertension, coupled with a suspicious weight loss history, further investigations were carried out. The full blood count revealed microcytic anaemia, thrombocytopenia, leukocytosis and lymphocytosis.

The blood film showed primitive atypical lymphoid cells with flow cytometry confirming a clonal population of B-cells.

Subsequent investigations with haematology included a bone marrow biopsy, cytogenetics and next-generation sequencing, leading to the final diagnosis of B-PLL with TP53 mutation. The patient has since undergone chemotherapy with rituximab and bendamustine with good clinical response.

View Figure 1.

Discussion

As mentioned previously, preretinal haemorrhages in young patients are uncommon and usually due to trauma, valsalva or malformation of the retinal vasculature.[[2]] However, in this case, further investigations revealed systemic B-PLL .

Ocular involvement of leukaemia—such as preretinal haemorrhages—can occur due to direct leukaemic infiltration or as a result of abnormal blood components, such as thrombocytopaenia and leucocytosis.[[3]] Although very uncommon, these signs can precede other systemic features.[[3]]

B-PLL is a rare, highly aggressive disorder and carries a poor prognosis. It is described as a mature lymphoid malignancy and accounts for approximately 2% of all lymphoid leukaemia only when combined with T-cell prolymphocytic leukaemia.[[4]]

B-PLL is separate from chronic lymphocytic leukaemia in several ways including physical signs, morphology, cell markers and clinical progression. B-PLL usually affects elderly patients above 70 years of age, and the common presentation involves splenomegaly without lymphadenopathy. Anaemia and thrombocytopenia are seen in at least 50% of cases.[[5]] Despite active treatment, median survival in these cases is 3 years.[[6]] It is exceedingly rare for patients to present with isolated ocular manifestations of this disease. Most reported cases are linked to chronic myelogenous leukaemia (CML)[[7]] and at time of submission this is the only case of B-PLL presenting this way.

This case highlights the importance of thorough investigative work as well as high clinical suspicion for other diagnoses when clinical history does not match presentation. In this case, the patient was diagnosed before any systemic features of the disease and was able to start treatment promptly, hopefully aiding with better prognosis.

Summary

Abstract

Aim

Method

Results

Conclusion

Author Information

Dr Luke Hawley: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Oscar Eaton: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Louis Han: Registrar, Department of Ophthalmology, Christchurch Public Hospital, Canterbury District Health Board.

Acknowledgements

We would like to thank our patient who has provided written consent for medical information to be published in this manuscript.

Correspondence

Dr Luke Hawley MBChB, BSc: Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board, 201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand.

Correspondence Email

E: Lhaw026@aucklanduni.ac.nz

Competing Interests

There are no competing interests to declare. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient for publication of this case report and accompanying images.

1) Mennel S. Subhyaloidal and macular haemorrhage: localisation and treatment strategies. Br J Ophthalmol. 2007;91(7):850-2.

2) Aumiller MS, Rinehart J. Multi‐layered haemorrhage secondary to retinal arterial macroaneurysm: a case report and review. Clin Exp Optom. 2015;98(2):117-21.

3) Hafeez MU, Ali MH, Najib N, Ayub MH, Shafi K, Munir M, Butt NH. Ophthalmic Manifestations of Acute Leukemia. Cureus. 2019;11(1):e3837.

4) Cross M, Dearden C. B and T cell prolymphocytic leukaemia. Best Pract Res Clin Haematol. 2019;32(3):217-28.

5) Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B‐and T‐cell subtype: a state‐of‐the‐art paper. Eur J Haematol. 2008;80(6):469-76.

6) Krishnan B, Matutes E, Dearden C. Prolymphocytic leukemias. Seminars in Oncology. 2006;33(2):257-263.

7) Huang PK, Sanjay S. Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia. Middle East Afr J Ophthalmol. 2011;18(4):336-8.

For the PDF of this article,
contact nzmj@nzma.org.nz

View Article PDF

Visual changes are a common presentation to the emergency department and appropriate work-up is paramount. This case shows how fundoscopy findings alone alerted the medical practitioners to a life-changing, exceedingly rare systemic illness. Preretinal haemorrhages form between the hyaloid face and the inner limiting membrane of the retina, and may occur in cases of diabetes, trauma or older age.[[1]] However, in younger patients it is an uncommon clinical finding. This is the first reported case of B-cell prolymphocytic leukaemia (B-PLL) presenting with visual symptoms.

Case report

A 39-year-old Caucasian man presented to the emergency eye clinic with left eye visual field changes. Initially it was described as a haze with shimmering lights, which then progressed to a small central scotoma (blind spot). The patient had no other associated ocular symptoms nor a history of trauma. However, on further questioning, he reported an unintended weight loss of 20 kilograms over the prior 2 months. This was attributed to a loss of appetite since starting a new medication (methylphenidate).

At presentation, his Snellen visual acuities were 6/4.5 in the right, and 6/7.5 in the left eye. The slit-lamp exam revealed a small oval-shaped pre-retinal haemorrhage inferonasal to the fovea in the left eye, as seen in the figure.

The differential diagnosis for a young patient with a preretinal haemorrhage includes trauma, valsalva retinopathy, retinal arteriolar macroaneurysm and blood disorders. As there was no history of valsalva maneuver nor hypertension, coupled with a suspicious weight loss history, further investigations were carried out. The full blood count revealed microcytic anaemia, thrombocytopenia, leukocytosis and lymphocytosis.

The blood film showed primitive atypical lymphoid cells with flow cytometry confirming a clonal population of B-cells.

Subsequent investigations with haematology included a bone marrow biopsy, cytogenetics and next-generation sequencing, leading to the final diagnosis of B-PLL with TP53 mutation. The patient has since undergone chemotherapy with rituximab and bendamustine with good clinical response.

View Figure 1.

Discussion

As mentioned previously, preretinal haemorrhages in young patients are uncommon and usually due to trauma, valsalva or malformation of the retinal vasculature.[[2]] However, in this case, further investigations revealed systemic B-PLL .

Ocular involvement of leukaemia—such as preretinal haemorrhages—can occur due to direct leukaemic infiltration or as a result of abnormal blood components, such as thrombocytopaenia and leucocytosis.[[3]] Although very uncommon, these signs can precede other systemic features.[[3]]

B-PLL is a rare, highly aggressive disorder and carries a poor prognosis. It is described as a mature lymphoid malignancy and accounts for approximately 2% of all lymphoid leukaemia only when combined with T-cell prolymphocytic leukaemia.[[4]]

B-PLL is separate from chronic lymphocytic leukaemia in several ways including physical signs, morphology, cell markers and clinical progression. B-PLL usually affects elderly patients above 70 years of age, and the common presentation involves splenomegaly without lymphadenopathy. Anaemia and thrombocytopenia are seen in at least 50% of cases.[[5]] Despite active treatment, median survival in these cases is 3 years.[[6]] It is exceedingly rare for patients to present with isolated ocular manifestations of this disease. Most reported cases are linked to chronic myelogenous leukaemia (CML)[[7]] and at time of submission this is the only case of B-PLL presenting this way.

This case highlights the importance of thorough investigative work as well as high clinical suspicion for other diagnoses when clinical history does not match presentation. In this case, the patient was diagnosed before any systemic features of the disease and was able to start treatment promptly, hopefully aiding with better prognosis.

Summary

Abstract

Aim

Method

Results

Conclusion

Author Information

Dr Luke Hawley: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Oscar Eaton: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Louis Han: Registrar, Department of Ophthalmology, Christchurch Public Hospital, Canterbury District Health Board.

Acknowledgements

We would like to thank our patient who has provided written consent for medical information to be published in this manuscript.

Correspondence

Dr Luke Hawley MBChB, BSc: Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board, 201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand.

Correspondence Email

E: Lhaw026@aucklanduni.ac.nz

Competing Interests

There are no competing interests to declare. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient for publication of this case report and accompanying images.

1) Mennel S. Subhyaloidal and macular haemorrhage: localisation and treatment strategies. Br J Ophthalmol. 2007;91(7):850-2.

2) Aumiller MS, Rinehart J. Multi‐layered haemorrhage secondary to retinal arterial macroaneurysm: a case report and review. Clin Exp Optom. 2015;98(2):117-21.

3) Hafeez MU, Ali MH, Najib N, Ayub MH, Shafi K, Munir M, Butt NH. Ophthalmic Manifestations of Acute Leukemia. Cureus. 2019;11(1):e3837.

4) Cross M, Dearden C. B and T cell prolymphocytic leukaemia. Best Pract Res Clin Haematol. 2019;32(3):217-28.

5) Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B‐and T‐cell subtype: a state‐of‐the‐art paper. Eur J Haematol. 2008;80(6):469-76.

6) Krishnan B, Matutes E, Dearden C. Prolymphocytic leukemias. Seminars in Oncology. 2006;33(2):257-263.

7) Huang PK, Sanjay S. Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia. Middle East Afr J Ophthalmol. 2011;18(4):336-8.

For the PDF of this article,
contact nzmj@nzma.org.nz

View Article PDF

Visual changes are a common presentation to the emergency department and appropriate work-up is paramount. This case shows how fundoscopy findings alone alerted the medical practitioners to a life-changing, exceedingly rare systemic illness. Preretinal haemorrhages form between the hyaloid face and the inner limiting membrane of the retina, and may occur in cases of diabetes, trauma or older age.[[1]] However, in younger patients it is an uncommon clinical finding. This is the first reported case of B-cell prolymphocytic leukaemia (B-PLL) presenting with visual symptoms.

Case report

A 39-year-old Caucasian man presented to the emergency eye clinic with left eye visual field changes. Initially it was described as a haze with shimmering lights, which then progressed to a small central scotoma (blind spot). The patient had no other associated ocular symptoms nor a history of trauma. However, on further questioning, he reported an unintended weight loss of 20 kilograms over the prior 2 months. This was attributed to a loss of appetite since starting a new medication (methylphenidate).

At presentation, his Snellen visual acuities were 6/4.5 in the right, and 6/7.5 in the left eye. The slit-lamp exam revealed a small oval-shaped pre-retinal haemorrhage inferonasal to the fovea in the left eye, as seen in the figure.

The differential diagnosis for a young patient with a preretinal haemorrhage includes trauma, valsalva retinopathy, retinal arteriolar macroaneurysm and blood disorders. As there was no history of valsalva maneuver nor hypertension, coupled with a suspicious weight loss history, further investigations were carried out. The full blood count revealed microcytic anaemia, thrombocytopenia, leukocytosis and lymphocytosis.

The blood film showed primitive atypical lymphoid cells with flow cytometry confirming a clonal population of B-cells.

Subsequent investigations with haematology included a bone marrow biopsy, cytogenetics and next-generation sequencing, leading to the final diagnosis of B-PLL with TP53 mutation. The patient has since undergone chemotherapy with rituximab and bendamustine with good clinical response.

View Figure 1.

Discussion

As mentioned previously, preretinal haemorrhages in young patients are uncommon and usually due to trauma, valsalva or malformation of the retinal vasculature.[[2]] However, in this case, further investigations revealed systemic B-PLL .

Ocular involvement of leukaemia—such as preretinal haemorrhages—can occur due to direct leukaemic infiltration or as a result of abnormal blood components, such as thrombocytopaenia and leucocytosis.[[3]] Although very uncommon, these signs can precede other systemic features.[[3]]

B-PLL is a rare, highly aggressive disorder and carries a poor prognosis. It is described as a mature lymphoid malignancy and accounts for approximately 2% of all lymphoid leukaemia only when combined with T-cell prolymphocytic leukaemia.[[4]]

B-PLL is separate from chronic lymphocytic leukaemia in several ways including physical signs, morphology, cell markers and clinical progression. B-PLL usually affects elderly patients above 70 years of age, and the common presentation involves splenomegaly without lymphadenopathy. Anaemia and thrombocytopenia are seen in at least 50% of cases.[[5]] Despite active treatment, median survival in these cases is 3 years.[[6]] It is exceedingly rare for patients to present with isolated ocular manifestations of this disease. Most reported cases are linked to chronic myelogenous leukaemia (CML)[[7]] and at time of submission this is the only case of B-PLL presenting this way.

This case highlights the importance of thorough investigative work as well as high clinical suspicion for other diagnoses when clinical history does not match presentation. In this case, the patient was diagnosed before any systemic features of the disease and was able to start treatment promptly, hopefully aiding with better prognosis.

Summary

Abstract

Aim

Method

Results

Conclusion

Author Information

Dr Luke Hawley: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Oscar Eaton: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Louis Han: Registrar, Department of Ophthalmology, Christchurch Public Hospital, Canterbury District Health Board.

Acknowledgements

We would like to thank our patient who has provided written consent for medical information to be published in this manuscript.

Correspondence

Dr Luke Hawley MBChB, BSc: Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board, 201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand.

Correspondence Email

E: Lhaw026@aucklanduni.ac.nz

Competing Interests

There are no competing interests to declare. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient for publication of this case report and accompanying images.

1) Mennel S. Subhyaloidal and macular haemorrhage: localisation and treatment strategies. Br J Ophthalmol. 2007;91(7):850-2.

2) Aumiller MS, Rinehart J. Multi‐layered haemorrhage secondary to retinal arterial macroaneurysm: a case report and review. Clin Exp Optom. 2015;98(2):117-21.

3) Hafeez MU, Ali MH, Najib N, Ayub MH, Shafi K, Munir M, Butt NH. Ophthalmic Manifestations of Acute Leukemia. Cureus. 2019;11(1):e3837.

4) Cross M, Dearden C. B and T cell prolymphocytic leukaemia. Best Pract Res Clin Haematol. 2019;32(3):217-28.

5) Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B‐and T‐cell subtype: a state‐of‐the‐art paper. Eur J Haematol. 2008;80(6):469-76.

6) Krishnan B, Matutes E, Dearden C. Prolymphocytic leukemias. Seminars in Oncology. 2006;33(2):257-263.

7) Huang PK, Sanjay S. Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia. Middle East Afr J Ophthalmol. 2011;18(4):336-8.

Contact diana@nzma.org.nz
for the PDF of this article

View Article PDF

Visual changes are a common presentation to the emergency department and appropriate work-up is paramount. This case shows how fundoscopy findings alone alerted the medical practitioners to a life-changing, exceedingly rare systemic illness. Preretinal haemorrhages form between the hyaloid face and the inner limiting membrane of the retina, and may occur in cases of diabetes, trauma or older age.[[1]] However, in younger patients it is an uncommon clinical finding. This is the first reported case of B-cell prolymphocytic leukaemia (B-PLL) presenting with visual symptoms.

Case report

A 39-year-old Caucasian man presented to the emergency eye clinic with left eye visual field changes. Initially it was described as a haze with shimmering lights, which then progressed to a small central scotoma (blind spot). The patient had no other associated ocular symptoms nor a history of trauma. However, on further questioning, he reported an unintended weight loss of 20 kilograms over the prior 2 months. This was attributed to a loss of appetite since starting a new medication (methylphenidate).

At presentation, his Snellen visual acuities were 6/4.5 in the right, and 6/7.5 in the left eye. The slit-lamp exam revealed a small oval-shaped pre-retinal haemorrhage inferonasal to the fovea in the left eye, as seen in the figure.

The differential diagnosis for a young patient with a preretinal haemorrhage includes trauma, valsalva retinopathy, retinal arteriolar macroaneurysm and blood disorders. As there was no history of valsalva maneuver nor hypertension, coupled with a suspicious weight loss history, further investigations were carried out. The full blood count revealed microcytic anaemia, thrombocytopenia, leukocytosis and lymphocytosis.

The blood film showed primitive atypical lymphoid cells with flow cytometry confirming a clonal population of B-cells.

Subsequent investigations with haematology included a bone marrow biopsy, cytogenetics and next-generation sequencing, leading to the final diagnosis of B-PLL with TP53 mutation. The patient has since undergone chemotherapy with rituximab and bendamustine with good clinical response.

View Figure 1.

Discussion

As mentioned previously, preretinal haemorrhages in young patients are uncommon and usually due to trauma, valsalva or malformation of the retinal vasculature.[[2]] However, in this case, further investigations revealed systemic B-PLL .

Ocular involvement of leukaemia—such as preretinal haemorrhages—can occur due to direct leukaemic infiltration or as a result of abnormal blood components, such as thrombocytopaenia and leucocytosis.[[3]] Although very uncommon, these signs can precede other systemic features.[[3]]

B-PLL is a rare, highly aggressive disorder and carries a poor prognosis. It is described as a mature lymphoid malignancy and accounts for approximately 2% of all lymphoid leukaemia only when combined with T-cell prolymphocytic leukaemia.[[4]]

B-PLL is separate from chronic lymphocytic leukaemia in several ways including physical signs, morphology, cell markers and clinical progression. B-PLL usually affects elderly patients above 70 years of age, and the common presentation involves splenomegaly without lymphadenopathy. Anaemia and thrombocytopenia are seen in at least 50% of cases.[[5]] Despite active treatment, median survival in these cases is 3 years.[[6]] It is exceedingly rare for patients to present with isolated ocular manifestations of this disease. Most reported cases are linked to chronic myelogenous leukaemia (CML)[[7]] and at time of submission this is the only case of B-PLL presenting this way.

This case highlights the importance of thorough investigative work as well as high clinical suspicion for other diagnoses when clinical history does not match presentation. In this case, the patient was diagnosed before any systemic features of the disease and was able to start treatment promptly, hopefully aiding with better prognosis.

Summary

Abstract

Aim

Method

Results

Conclusion

Author Information

Dr Luke Hawley: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Oscar Eaton: Non-Training Registrar, Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board. Dr Louis Han: Registrar, Department of Ophthalmology, Christchurch Public Hospital, Canterbury District Health Board.

Acknowledgements

We would like to thank our patient who has provided written consent for medical information to be published in this manuscript.

Correspondence

Dr Luke Hawley MBChB, BSc: Department of Ophthalmology, Dunedin Public Hospital, Southern District Health Board, 201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand.

Correspondence Email

E: Lhaw026@aucklanduni.ac.nz

Competing Interests

There are no competing interests to declare. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee(s) and with the Helsinki Declaration (as revised in 2013). Written informed consent was obtained from the patient for publication of this case report and accompanying images.

1) Mennel S. Subhyaloidal and macular haemorrhage: localisation and treatment strategies. Br J Ophthalmol. 2007;91(7):850-2.

2) Aumiller MS, Rinehart J. Multi‐layered haemorrhage secondary to retinal arterial macroaneurysm: a case report and review. Clin Exp Optom. 2015;98(2):117-21.

3) Hafeez MU, Ali MH, Najib N, Ayub MH, Shafi K, Munir M, Butt NH. Ophthalmic Manifestations of Acute Leukemia. Cureus. 2019;11(1):e3837.

4) Cross M, Dearden C. B and T cell prolymphocytic leukaemia. Best Pract Res Clin Haematol. 2019;32(3):217-28.

5) Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B‐and T‐cell subtype: a state‐of‐the‐art paper. Eur J Haematol. 2008;80(6):469-76.

6) Krishnan B, Matutes E, Dearden C. Prolymphocytic leukemias. Seminars in Oncology. 2006;33(2):257-263.

7) Huang PK, Sanjay S. Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia. Middle East Afr J Ophthalmol. 2011;18(4):336-8.

Contact diana@nzma.org.nz
for the PDF of this article

Subscriber Content

The full contents of this pages only available to subscribers.
Login, subscribe or email nzmj@nzma.org.nz to purchase this article.

LOGINSUBSCRIBE
No items found.